Dar, Owais
Dulay, Mansimran Singh http://orcid.org/0009-0002-2319-8876
Riesgo-Gil, Fernando
Morley-Smith, Andrew
Brookes, Paul
Lyster, Haifa
Rice, Alexandra
Underwood, Stephen R.
Dunning, John
Wechalekar, Kshama
Article History
Received: 5 January 2024
Accepted: 21 January 2024
First Online: 19 April 2024
Declarations
:
: Institutional review board at Royal Brompton and Harefield Hospitals Clinical Practice Committee approved the off-label use of FDG PET imaging in the diagnosis and management of suspected rejection in HTx recipients at Harefield Hospital. The project was registered with the clinical audit committee (project identification number 005091) in accordance with the trust governance policy.
: All applicable consent was obtained from patient participants prior to conducting our research.
: All authors declare no conflicts of interest.